化工社化工社 化学情報印刷レポート · 研究参考用
Imidazole → 3-Tert-butyldimethylsilyloxy-17-cyclopropylmethyl-4,5alpha-epoxy-14beta-hydroxy-6-oxomorphinan
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Imidazole | HCID 795 | — |
| 反応物 | Water | HCID 962 | — |
| 反応物 | tert-Butyldimethylsilyl chloride | HCID 28928 | — |
| 反応物 | Naltrexone Hydrochloride | HCID 5485201 | — |
| 溶媒 | Diethyl Ether | HCID 3283 | — |
| 溶媒 | Dimethylformamide | HCID 6228 | — |
| 生成物 | 3-Tert-butyldimethylsilyloxy-17-cyclopropylmethyl-4,5alpha-epoxy-14beta-hydroxy-6-oxomorphinan | HCID 14394779 | 76% |
反応手順
3.49 g of naltrexone hydrochloride was suspended in 10.5 ml of N,N-dimethylformamide. After adding 3.46 g of imidazole, 3.48 g of tert-butyldimethylchlorosilane was added followed by stirring for 35 minutes at room temperature. 30 ml of water and 50 ml of diethyl ether were added to the reaction system followed by separation. The aqueous layer was extracted twice with 30 ml of diethyl ether. The combined extracts were dried over anhydrous sodium sulfate and concentrated. The resulting residue was recrystallized from ethanol to obtain 3.2 g of the target compound (yield: 76%).
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US06177438B1 |
| 出典データセット | uspto-grants-2001_01 |
| ORD ID | ord-62f86fc05582497fb1f41dc0b98fd041 |
| 出典メモ | uspto-grants-2001_01 |